000 | 01969 a2200577 4500 | ||
---|---|---|---|
005 | 20250515221341.0 | ||
264 | 0 | _c20100902 | |
008 | 201009s 0 0 eng d | ||
022 | _a1872-6240 | ||
024 | 7 |
_a10.1016/j.brainres.2010.04.014 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHe, Liu-fang | |
245 | 0 | 0 |
_aCurcumin protects pre-oligodendrocytes from activated microglia in vitro and in vivo. _h[electronic resource] |
260 |
_bBrain research _cJun 2010 |
||
300 |
_a60-9 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aAnimals, Newborn |
650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xpharmacology |
650 | 0 | 4 |
_aApoptosis _xdrug effects |
650 | 0 | 4 |
_aBrain _xdrug effects |
650 | 0 | 4 |
_aCell Communication _xdrug effects |
650 | 0 | 4 | _aCells, Cultured |
650 | 0 | 4 | _aCoculture Techniques |
650 | 0 | 4 |
_aCurcumin _xpharmacology |
650 | 0 | 4 | _aDrug Antagonism |
650 | 0 | 4 |
_aEnzyme Activation _xdrug effects |
650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInfant, Newborn |
650 | 0 | 4 |
_aLeukomalacia, Periventricular _xpathology |
650 | 0 | 4 |
_aLipopolysaccharides _xtoxicity |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMembrane Glycoproteins _xmetabolism |
650 | 0 | 4 |
_aMicroglia _xcytology |
650 | 0 | 4 | _aNADPH Oxidase 2 |
650 | 0 | 4 |
_aNADPH Oxidases _xmetabolism |
650 | 0 | 4 |
_aNeuroprotective Agents _xpharmacology |
650 | 0 | 4 |
_aNitric Oxide Synthase Type II _xmetabolism |
650 | 0 | 4 |
_aOligodendroglia _xcytology |
650 | 0 | 4 |
_aPhosphoproteins _xmetabolism |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
700 | 1 | _aChen, Hui-Jin | |
700 | 1 | _aQian, Long-hua | |
700 | 1 | _aChen, Guan-yi | |
700 | 1 | _aBuzby, Jeffrey S | |
773 | 0 |
_tBrain research _gvol. 1339 _gp. 60-9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.brainres.2010.04.014 _zAvailable from publisher's website |
999 |
_c19761419 _d19761419 |